Organized around the objective of extending the “Golden Hour” for survival - saving limbs and lives - Amsel Medical Corporation has developed and manufactures an occluder device designed to secure close blood vessels as well as tubular structures during open surgical procedures. The system is anchored in existing surgical clamping technology that helps blood vessels to heal faster with minimally invasive needle delivery. This results in secure occlusion similar to that of a transfixion suture and eliminates slippage, enabling medical professionals to treat venous reflux disease and occlude vessels of varying sizes, types, and wall thickness. The firm's trauma management and hemorrhage control solution - the SCureTO - is designed to reduce mortality rates while also minimizing limb loss. Junctional and non-compressible hemorrhage in the battlefield is responsible for greater than 60% mortality amongst US combatants and is also a major cause of mortality and morbidity for civilian trauma victims. As such there is need for a solution that rapidly and effectively controls blood loss to improve survival and minimize limb ischemia.
